title: Methodological concerns regarding cost-effectiveness analysis of palivizumab in Florida Medicaid.
authors.forename: Parthiv J
authors.initials: PJ
authors.lastname: Mahadevia
authors.forename: Doris
authors.initials: D
authors.lastname: Makari
authors.forename: Anthony
authors.initials: A
authors.lastname: Masaquel
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics*; D000998:Antiviral Agents / Q000191:economics*; D005260:Female; D017048:Health Care Costs; D006801:Humans; D008297:Male; D018357:Respiratory Syncytial Virus Infections / Q000191:economics* / Q000517:prevention & control*
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents